InfanDx focuses on unmet diagnostic needs for acute and critical care conditions affecting newborns. A key focus lies on solving the pressing issue of the early detection of Hypoxic-Ischemic Encephalopathy (HIE). Further, InfanDx is working on novel opportunities in prenatal testing and infant health with the intention of supporting timely and informed clinical decision making, ensuring the best possible outcomes for the most vulnerable of all patients: the Child.